24-hour bronchodilator efficacy of single doses of indacaterol in subjects with COPD: comparison with placebo and formoterol

By Bauwens Olivier   Ninane Vincent   Van de Maele Boudewijn   Firth Roz   Dong Fang   Owen Roger   Higgins Mark  

Current Medical Research and Opinion, Vol. 25, Iss. 2, 2009-02 ,pp. : 463-470

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma

By Brookman Laurence J.   Knowles Lisa J.   Barbier Michaela   Elharrar Brigitte   Fuhr Rainard   Pascoe Steve  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3113-3122

Informa Healthcare

Access to resources Recommend Favorite

Bronchoprotective and Bronchodilator Effects of an HFA pMDI vs. a CFC pMDI and a DPI Containing Formoterol in Asthma Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 35-37

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Efficacy Crossover Trial Comparing Formoterol-HFA (pMDI) versus Formoterol-DPI (Aerolizer^TM) and Placebo (pMDI or Aerolizer^TM) in Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 6-12

Karger

Access to resources Recommend Favorite

A Randomized, Double-Blind, Double-Dummy, Single-Dose, Crossover Trial Evaluating the Efficacy and Safety Profiles of Two Dose Levels (12 and 24 μg) of Formoterol-HFA (pMDI) vs. Those of a Dose Level (24 μg) of Formoterol-DPI (Foradil^®/Aerolizer^™) and of Placebo (pMDI or Aerolizer) in Moderate to Severe Asthmatic Patients

By  

Respiration, Vol. 72, Iss. 1, 2005-05 ,pp. : 13-19

Karger

Access to resources Recommend Favorite